http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57165383-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
filingDate 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8a9c1bc889f04b6ed791ba9a6a62499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a003e516b0070f4851f6e5ac45810acf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b45e663ab3ee9bb0604b862f44baa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9160acda744ecab614f32182fb248378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c770f8fe49600c6a4da6a0e813be59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3e031c2c78c88ee6aed81c1b9b7b78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08cc131ed8a82d49cd5d79f8e408787e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc73a53703b5cdb6582ae13ea7614f2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1216d44ad651531644e2ea82b190b5c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c247b3bab7eff298cd96066158853b2
publicationDate 1982-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57165383-A
titleOfInvention Prostaglandin i1 derivative and its preparation
abstract NEW MATERIAL:The compound of formulaI(R 1 is H or lower alkyl; R 2 is 1W10C alkyl or cycloalkyl; R 3 is H or methyl; R 4 and R 5 are H or protecting group), or when R 1 is H, the non-toxic salt of the acid. n EXAMPLE: 4-Thiaprostaglandin I 1 methyl ester 11,15-bis-t-butyl dimethylsilyl ether. n USE: Useful as a remedy for gastric ulcer, duodenal ulcer and asthma. It has antiulcer and antiasthmatic activity. n PROCESS: The compound of formulaIis prepared by reacting the cyclopentanol derivative of formula II (R 4-1 and R 5-1 are protecting group) with the sulfenyl derivative of formula III (X is Cl, etc.) in an organic solvent at -80W+20°C, and if necessary, eliminating the protecting group and/or hydrolyzing the product. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457778434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519450

Total number of triples: 30.